APA

Lampron A., Bourdeau I., Hamet P., Tremblay J. & Lacroix A. (20061012). Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. : The Journal of clinical endocrinology and metabolism.

Chicago

Lampron Antoine, Bourdeau Isabelle, Hamet Pavel, Tremblay Johanne and Lacroix André. 20061012. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. : The Journal of clinical endocrinology and metabolism.

Harvard

Lampron A., Bourdeau I., Hamet P., Tremblay J. and Lacroix A. (20061012). Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. : The Journal of clinical endocrinology and metabolism.

MLA

Lampron Antoine, Bourdeau Isabelle, Hamet Pavel, Tremblay Johanne and Lacroix André. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. : The Journal of clinical endocrinology and metabolism. 20061012.